Single-Agent Investigational Therapies for Myeloproliferative Neoplasms
A key opinion leader details the single-agent therapies currently being investigated for the treatment of myeloproliferative neoplasms.
EP: 1.Overview of the Types of Myeloproliferative Neoplasms
EP: 2.Current Standards of Care for Polycythemia Vera and Essential Thrombocytosis
EP: 3.Overview of Myelofibrosis and the Challenges of Diagnosis
EP: 4.Approved Systemic Treatment Options for Myelofibrosis
EP: 5.Ruxolitinib Combination Therapies for Myeloproliferative Neoplasms
Now Viewing
EP: 6.Single-Agent Investigational Therapies for Myeloproliferative Neoplasms
EP: 7.Major Unmet Needs in Myeloproliferative Neoplasm Management
Related Videos
